Differences in Prediagnostic Serum Metabolomic and Lipidomic Profiles Between Cirrhosis Patients with and without Incident Hepatocellular Carcinoma.
Saved in:
| Title: | Differences in Prediagnostic Serum Metabolomic and Lipidomic Profiles Between Cirrhosis Patients with and without Incident Hepatocellular Carcinoma. |
|---|---|
| Authors: | Powell H; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Coarfa C; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.; Center for Precision Environmental Health, Baylor College of Medicine, Houston, TX, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Ruiz-Echartea E; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.; Center for Precision Environmental Health, Baylor College of Medicine, Houston, TX, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Grimm SL; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.; Center for Precision Environmental Health, Baylor College of Medicine, Houston, TX, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Najjar O; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Yu B; Department of Epidemiology, The University of Texas Health Science Center at Houston, Houston, TX, USA., Olivares L; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Scheurer ME; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Ballantyne C; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Alsarraj A; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Salem EM; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Thrift AP; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.; Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX, USA., El Serag HB; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Kaochar S; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA. |
| Source: | Journal of hepatocellular carcinoma [J Hepatocell Carcinoma] 2024 Sep 07; Vol. 11, pp. 1699-1712. Date of Electronic Publication: 2024 Sep 07 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Press Country of Publication: New Zealand NLM ID: 101674775 Publication Model: eCollection Cited Medium: Print ISSN: 2253-5969 (Print) Linking ISSN: 22535969 NLM ISO Abbreviation: J Hepatocell Carcinoma Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2253-5969 |
|---|---|
| DOI: | 10.2147/JHC.S474010 |
